Literature DB >> 7685275

Neuron-specific expression and physiological regulation of bovine vasopressin transgenes in mice.

H L Ang1, D A Carter, D Murphy.   

Abstract

We have used transgenic mice to analyse the regulation of the bovine vasopressin (BVP) gene. We find that the restriction of BVP gene expression to anatomically and functionally distinct hypothalamic neuronal groups is achieved, in part, by selective repression. The expression of a 1.25 kb BVP proximal promoter, which on its own confers general expression of a reporter to most peripheral and brain tissues, was limited by sequences in the BVP structural gene to neural cells in the adrenal medulla and brain. Transgene expression in the hypothalamus was shown to be regulated by the physiological stimulus of dehydration in parallel with the endogenous gene. The expression of a larger 13.4 kb BVP transgene, containing 9 kb of 5' upstream sequence, the VP structural gene and 1.5 kb 3' of the transcription unit, was even more restricted and resembles that of the endogenous mouse gene. Hypothalamic expression of the 13.4 kb BVP transgene was regulated appropriately in response to an osmotic challenge.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685275      PMCID: PMC413474          DOI: 10.1002/j.1460-2075.1993.tb05894.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  53 in total

Review 1.  Neuropeptide gene expression in transgenic animals.

Authors:  D Murphy; H L Ang; Q Zeng; M Y Ho; J Funkhouser; D Carter
Journal:  Prog Brain Res       Date:  1992       Impact factor: 2.453

2.  Synthesis, transport, and release of posterior pituitary hormones.

Authors:  M J Brownstein; J T Russell; H Gainer
Journal:  Science       Date:  1980-01-25       Impact factor: 47.728

Review 3.  Organization and function of a central nervous system circadian oscillator: the suprachiasmatic hypothalamic nucleus.

Authors:  R Y Moore
Journal:  Fed Proc       Date:  1983-08

4.  Hypothalamic integration: organization of the paraventricular and supraoptic nuclei.

Authors:  L W Swanson; P E Sawchenko
Journal:  Annu Rev Neurosci       Date:  1983       Impact factor: 12.449

5.  Vasopressin and adrenal cortical interactions.

Authors:  E A Zimmerman; A J Silverman
Journal:  Prog Brain Res       Date:  1983       Impact factor: 2.453

6.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

7.  Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo.

Authors:  C Rivier; W Vale
Journal:  Endocrinology       Date:  1983-09       Impact factor: 4.736

Review 8.  Immunocytochemical localization of the vertebrate cyclic nonapeptide neurohypophyseal hormones and neurophysins.

Authors:  K Dierickx
Journal:  Int Rev Cytol       Date:  1980

9.  Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin.

Authors:  G E Gillies; E A Linton; P J Lowry
Journal:  Nature       Date:  1982-09-23       Impact factor: 49.962

10.  Structural organization of the rat gene for the arginine vasopressin-neurophysin precursor.

Authors:  H Schmale; S Heinsohn; D Richter
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  8 in total

1.  Promoter transgenics reveal multiple gonadotropin-releasing hormone-I-expressing cell populations of different embryological origin in mouse brain.

Authors:  M J Skynner; R Slater; J A Sim; N D Allen; A E Herbison
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

2.  Transgenic rats reveal functional conservation of regulatory controls between the Fugu isotocin and rat oxytocin genes.

Authors:  B Venkatesh; S L Si-Hoe; D Murphy; S Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

Review 3.  Transgenic and transcriptional studies on neurosecretory cell gene expression.

Authors:  S J Waller; A Ratty; J P Burbach; D Murphy
Journal:  Cell Mol Neurobiol       Date:  1998-04       Impact factor: 5.046

4.  Authentic cell-specific and developmentally regulated expression of pro-opiomelanocortin genomic fragments in hypothalamic and hindbrain neurons of transgenic mice.

Authors:  J I Young; V Otero; M G Cerdán; T L Falzone; E C Chan; M J Low; M Rubinstein
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

Review 5.  Transgenic targeting of neuroendocrine peptide genes in the hypothalamic-pituitary axis.

Authors:  J A Waschek
Journal:  Mol Neurobiol       Date:  1995 Apr-Jun       Impact factor: 5.590

6.  Transgenesis and neuroendocrine physiology: a transgenic rat model expressing growth hormone in vasopressin neurones.

Authors:  Sara E Wells; David M Flavell; Gordon W Bisset; Pamela A Houston; Helen Christian; Keith M Fairhall; Iain C A F Robinson
Journal:  J Physiol       Date:  2003-06-17       Impact factor: 5.182

7.  Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer.

Authors:  J M Coulson; J Stanley; P J Woll
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

8.  Identification of brain-derived neurotrophic factor promoter regions mediating tissue-specific, axotomy-, and neuronal activity-induced expression in transgenic mice.

Authors:  T Timmusk; U Lendahl; H Funakoshi; E Arenas; H Persson; M Metsis
Journal:  J Cell Biol       Date:  1995-01       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.